Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Multiple Myeloma 11 Neoplasms 8 Vomiting 6 Nausea 5 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Pain, Postoperative 2 Neoplasm, Residual 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Wrist Fractures 1 Systemic Inflammatory Response Syndrome 1 Supratentorial Neoplasms 1 Radicular Cyst 1 Postoperative Nausea and Vomiting 1 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Mediastinal Neoplasms 1 Malnutrition 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphohistiocytosis, Hemophagocytic 1

Interventions

spartalizumab 1 ruxolitinib 1 dolutegravir 1 Rituximab 1 Ritonavir 1 Nucleosides 1 Dexamethasone 1 Darunavir 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Epstein-Barr Virus Infections × Dexamethasone × Clear all

NCT05039580 2021-09-09

SEHC

The First Affiliated Hospital of Soochow University

Phase 4 Unknown

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡